Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus long-acting octreotide for polycystic liver volume reduction
2009-016640-39Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus in Polycystic liver disease (PLD), sponsored by Radboud University Medical Center. Started Dec 2009; status: completed.
02
Drugs
everolimus
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on 2009-016640-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016640-39.